EUVIMEDEUVIMED entdecken
Crossref

HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer

Liuxu Yang, Ruizhe Wang, Lun Zhang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04228-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Liuxu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an JiaoTong University, Xian, Shaanxi, 710061, China. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, Annexin A2, Deoxycytidine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy resistance contributes to the unsatisfied prognosis in pancreatic cancer (PC) patients. Heat shock protein beta-1 (HSPB1) plays a tumor promoting role in PC by inhibiting ferroptosis. This study aims to explore whether high expression of HSPB1 was responsible for ferroptosis and gemcitabine (GEM) resistance in PC. Here, we found that HSPB1 was upregulated in GEM-resistant PC cells and tumor tissues, as confirmed by RT-qPCR and Western blotting assays. Knockdown of HSPB1 enhanced GEM sensitivity, decreased the abilities of proliferation and invasion, and promoted apoptosis in GEM-resistant PC cells. Utilizing commercial kits, HSPB1 inhibition triggered ferroptosis, as indicated by increased levels of reactive oxygen species, malondialdehyde, and Fe2+, along with reduced glutathione (GSH) levels. Furthermore, the methylation specific PCR (MSP) results demonstrated a significant decrease in the methylation level of annexin A2 (ANXA2) CpG. The Chromatin immunoprecipitation (ChIP), ChIP-Re-ChIP, and Co-IP experiments revealed that HSPB1 interacts with lysine-specific histone demethylase 1A (KDM1A), recruiting KDM1A-CoREST complex to the ANXA2 promoter to enhance ANXA2 expression through demethylation of H3K9me2. Additionally, ANXA2 depletion further inhibited cell proliferation and invasion and induced ferroptosis in KDM1A-silenced cells, whereas ANXA2 overexpression produced the opposite effects. Finally, HSPB1 overexpression reduced gemcitabine sensitivity by promoting tumor growth in nude mice. Altogether, HSPB1 promoted ANXA2 expression by facilitating H3K9me2 demethylation through the recruitment of KDM1A-CoREST complex to the ANXA2 promoter, thereby inhibiting ferroptosis and enhancing GEM resistance in PC. These data provided a new insight for overcoming GEM-resistant PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPancreatic NeoplasmsAnnexin A2DeoxycytidineAntimetabolites, AntineoplasticHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansDrug Resistance, NeoplasmAnimalsPromoter Regions, GeneticGemcitabineCell Line, TumorMice, NudeMolecular ChaperonesMiceDNA MethylationMaleMice, Inbred BALB CFemaleGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ANXA2FerroptosisGemcitabine resistanceHSPB1HypomethylationKDM1 APancreatic cancer

Substanzen

Annexin A2GemcitabineMolecular ChaperonesANXA2 protein, humanDeoxycytidineHSPB1 protein, humanAntimetabolites, AntineoplasticHeat-Shock ProteinsHSP27 Heat-Shock Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an JiaoTong University, Xian, Shaanxi, 710061, China.
  • Health Science Center, Xi'an JiaoTong University, Xian, Shaanxi, 710061, China.
  • Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an JiaoTong University, Xian, Shaanxi, 710061, China. zhanglun3781@stu.xjtu.edu.cn.

Zitieren

APA

Yang, L., Wang, R., & Zhang, L. (2025). HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04228-2

Vancouver

Yang L, Wang R, Zhang L. HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04228-2

BibTeX
@article{Yang2025,
  author = {Yang, Liuxu and Wang, Ruizhe and Zhang, Lun},
  title = {HSPB1/KDM1 A facilitates ANXA2 expression via hypomethylated DNA promoter to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04228-2}
}
Kostenlos starten →